Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 935 $ 12
Restricted cash 5
Trade receivables 378
Inventories 536
Other current assets 601 9
Total current assets 2,450 26
Non-current assets:    
Investment in affiliated companies accounted for under equity method, net 745
Investment in other company 224 [1]
Property and equipment, net 1,999 65
Prepaid expenses 591
Total non-current assets 3,559 65
Total assets 6,009 91
Current liabilities:    
Receivables financing facility, net 1,306
Loans, net 1,672 113
Accounts payable 1,640 415
Deferred revenues 844
Other current liabilities 2,316 800
Liability for minimum royalties 291 235
Total current liabilities 8,069 1,563
Non-current liabilities:    
Loans from shareholders 310
Convertible bridge loans, net 5,965 3,427
Derivative warrants liability, net 301 752
Fair value of bifurcated convertible feature of convertible bridge loans 2,500
Liability for minimum royalties 185 188
Other non-current liabilities 100
Total non-current liabilities 8,951 4,777
Commitments and contingent liabilities
Shareholders' deficit:    
Ordinary Shares of NIS 0.01 par value each: Authorized: 1,000,000,000 shares at December 31, 2020 and 2019; Issued and outstanding: 376,335,802 shares and 103,573,795 shares at December 31, 2020 and 2019, respectively 1,059 280
Additional paid-in capital 35,211 10,979
Accumulated deficit (47,281) (17,508)
Total shareholders' deficit (11,011) (6,249)
Total liabilities and shareholders' deficit $ 6,009 $ 91
[1] Representing an amount less than $1